Skip to main content
Top
Published in: Clinical and Molecular Allergy 1/2010

Open Access 01-12-2010 | Case Report

The increase of plasma galectin-9 in a patient with insulin allergy: a case report

Authors: Haorile Chagan-Yasutan, Beata Shiratori, Umme Ruman Siddiqi, Hiroki Saitoh, Yugo Ashino, Tomohiro Arikawa, Mitsuomi Hirashima, Toshio Hattori

Published in: Clinical and Molecular Allergy | Issue 1/2010

Login to get access

Abstract

Allergic reaction to insulin is known to be associated with eosinophilia and hyper IgE. Recent report showed that eosinophilia is related with the increased synthesis of galectin-9 (GAL-9) and osteopontin (OPN). Here, we examined plasma levels of GAL-9 and OPN first time in a case of 65-year old patient with insulin allergy. Insulin aspart & insulin aspart 30 mix were given to the patient and an elevation of the eosinophil count (8440/μl, 17.6 fold) and a moderate increase of IgE (501 U/ml, reference range: 10-350 U/ml), eotaxin-3 (168 pg/ml, 2 fold), histamine (0.95 ng/ml, 5.3 fold) were found 33 days later. The plasma levels of GAL-9 and OPN were 22.5 and 1.7 fold higher than the cut-off point, respectively. After one month cessation of insulin therapy, elevations of the eosinophil count (3,480/μl; 7.3 fold), and OPN (1.4 fold) still occurred but the GAL-9 levels became normal. Therefore, we noted the increases of GAL-9 and OPN in plasma for the first time in a patient with insulin allergy and propose that GAL-9 reflects the conditions of allergy more accurately.
Appendix
Available only for authorised users
Literature
1.
go back to reference Takata H, Kumon Y, Osaki F, Kumagai C, Arii K, Ikeda Y, Suehiro T, Hashimoto K: The human insulin analogue aspart is not the almighty solution for insulin allergy. Diabetes Care. 2003, 26: 253-254. 10.2337/diacare.26.1.253-aCrossRefPubMed Takata H, Kumon Y, Osaki F, Kumagai C, Arii K, Ikeda Y, Suehiro T, Hashimoto K: The human insulin analogue aspart is not the almighty solution for insulin allergy. Diabetes Care. 2003, 26: 253-254. 10.2337/diacare.26.1.253-aCrossRefPubMed
2.
go back to reference Puxeddu I, Berkman N, Ribatti D, Bader R, Haichi HM, Davies DE, Howarth PH, Levi-Schaffer F: Osteopontin is expressed and functional in human eosinophils. Allergy. 2010, 65: 168-174. 10.1111/j.1398-9995.2009.02148.xCrossRefPubMed Puxeddu I, Berkman N, Ribatti D, Bader R, Haichi HM, Davies DE, Howarth PH, Levi-Schaffer F: Osteopontin is expressed and functional in human eosinophils. Allergy. 2010, 65: 168-174. 10.1111/j.1398-9995.2009.02148.xCrossRefPubMed
3.
go back to reference Takahashi Y, Fukusato T, Kobayashi Y, Akiyama S, Tamatani T, Shiga J, Mori S: High expression of eosinophil chemoattratant ecalectin/galectin-9 in drug induced liver injury. Liver Int. 2006, 26: 106-115. 10.1111/j.1478-3231.2005.01189.xCrossRefPubMed Takahashi Y, Fukusato T, Kobayashi Y, Akiyama S, Tamatani T, Shiga J, Mori S: High expression of eosinophil chemoattratant ecalectin/galectin-9 in drug induced liver injury. Liver Int. 2006, 26: 106-115. 10.1111/j.1478-3231.2005.01189.xCrossRefPubMed
4.
go back to reference Chagan-Yasutan H, Saitoh H, Ashino Y, Arikawa T, Hirashima M, Li S, Usuzawa M, Oguma S, Telan EFO, Obi CL, Hattori T: Persistent elevation of plasma osteopontin levels in HIV patients despite highly active antiretroviral therapy. Tohoku J Exp Med. 2009, 218: 285-292. 10.1620/tjem.218.285CrossRefPubMed Chagan-Yasutan H, Saitoh H, Ashino Y, Arikawa T, Hirashima M, Li S, Usuzawa M, Oguma S, Telan EFO, Obi CL, Hattori T: Persistent elevation of plasma osteopontin levels in HIV patients despite highly active antiretroviral therapy. Tohoku J Exp Med. 2009, 218: 285-292. 10.1620/tjem.218.285CrossRefPubMed
5.
go back to reference Chou FC, Shieh SJ, Sytwu HK: Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice. Eur J Immunol. 2009, 39: 2403-2411. 10.1002/eji.200839177CrossRefPubMed Chou FC, Shieh SJ, Sytwu HK: Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice. Eur J Immunol. 2009, 39: 2403-2411. 10.1002/eji.200839177CrossRefPubMed
6.
go back to reference Kaito K, Otsubo H, Ogasawara Y, Kimura H, Kurihara E, Koike M, Aiso M, Kobayashi M: Serum soluble interleukin-2 receptor in eosinophilia. Acta Haematol. 2003, 109: 23-28. 10.1159/000067274CrossRefPubMed Kaito K, Otsubo H, Ogasawara Y, Kimura H, Kurihara E, Koike M, Aiso M, Kobayashi M: Serum soluble interleukin-2 receptor in eosinophilia. Acta Haematol. 2003, 109: 23-28. 10.1159/000067274CrossRefPubMed
7.
go back to reference Konikoff MR, Blanchard C, Kirby C, Buckmeier BK, Cohen MB, Heubi JE, Putnam PE, Rothenberg ME: Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2006, 4: 1328-1336. 10.1016/j.cgh.2006.08.013CrossRefPubMed Konikoff MR, Blanchard C, Kirby C, Buckmeier BK, Cohen MB, Heubi JE, Putnam PE, Rothenberg ME: Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2006, 4: 1328-1336. 10.1016/j.cgh.2006.08.013CrossRefPubMed
8.
go back to reference Kimura K, Adachi M, Kubo K, Ikemoto Y: The basal plasma histamine level and eosinophil count in allergic and non-allergic patients [abstract]. Fukuoka Igaku Zasshi. 1999, 90 (12): 457-463.PubMed Kimura K, Adachi M, Kubo K, Ikemoto Y: The basal plasma histamine level and eosinophil count in allergic and non-allergic patients [abstract]. Fukuoka Igaku Zasshi. 1999, 90 (12): 457-463.PubMed
9.
go back to reference Nagasaka A, Matsue H, Matsushima H, Aoki R, Nakamura Y, Kambe N, Kon S, Uede T, Shimada S: Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur J Immunol. 2008, 38: 489-499. 10.1002/eji.200737057CrossRefPubMed Nagasaka A, Matsue H, Matsushima H, Aoki R, Nakamura Y, Kambe N, Kon S, Uede T, Shimada S: Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur J Immunol. 2008, 38: 489-499. 10.1002/eji.200737057CrossRefPubMed
10.
go back to reference Zerler B: The soluble interleukin-2 receptor as a marker for human neoplasia and immune status. Cancer Cells. 1991, 3: 471-479.PubMed Zerler B: The soluble interleukin-2 receptor as a marker for human neoplasia and immune status. Cancer Cells. 1991, 3: 471-479.PubMed
11.
go back to reference Wiener Z, Kohalmi B, Pocza P, Jeager J, Tolgyesi G, Toth S, Gorbe E, Papp Z, Falus A: TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells. J Invest Dermatol. 2007, 127: 906-914. 10.1038/sj.jid.5700616CrossRefPubMed Wiener Z, Kohalmi B, Pocza P, Jeager J, Tolgyesi G, Toth S, Gorbe E, Papp Z, Falus A: TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells. J Invest Dermatol. 2007, 127: 906-914. 10.1038/sj.jid.5700616CrossRefPubMed
12.
go back to reference Katoh S, Nobumoto A, Matsumoto N, Matsumoto K, Ehara N, Niki T, Inada H, Nishi N, Yamauchi A, Fukushima K, Hirashima M: Involvement of galectin-9 in lung eosinophilia in patients with eosinophilic pneumonia. Int Arch Allergy Immunol. 2010, 153: 294-302. 10.1159/000314371CrossRefPubMed Katoh S, Nobumoto A, Matsumoto N, Matsumoto K, Ehara N, Niki T, Inada H, Nishi N, Yamauchi A, Fukushima K, Hirashima M: Involvement of galectin-9 in lung eosinophilia in patients with eosinophilic pneumonia. Int Arch Allergy Immunol. 2010, 153: 294-302. 10.1159/000314371CrossRefPubMed
13.
go back to reference Niki T, Tsutsui S, Hirose S, Aradono S, Sugimoto Y, Takeshita K, Nishi N, hirashima M: Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation. J Biol Chem. 2009, 284: 32344-32352. 10.1074/jbc.M109.035196PubMedCentralCrossRefPubMed Niki T, Tsutsui S, Hirose S, Aradono S, Sugimoto Y, Takeshita K, Nishi N, hirashima M: Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation. J Biol Chem. 2009, 284: 32344-32352. 10.1074/jbc.M109.035196PubMedCentralCrossRefPubMed
14.
go back to reference Rao SP, Wang Z, Zuberi RI, Sikora L, Bahaie NS, Zuraw BL, Liu FT, Sriramarao P: Galectin-3 functions as an adhesion molecule to support eosinophil rolling and adhesion under conditions of flow. J Immunol. 2007, 179: 7800-7807.CrossRefPubMed Rao SP, Wang Z, Zuberi RI, Sikora L, Bahaie NS, Zuraw BL, Liu FT, Sriramarao P: Galectin-3 functions as an adhesion molecule to support eosinophil rolling and adhesion under conditions of flow. J Immunol. 2007, 179: 7800-7807.CrossRefPubMed
15.
go back to reference Cortegano I, del Pozo V, Cárdaba B, de Andrés B, Gallardo S, del Amo A, Arrieta I, Jurado A, Palomino P, Liu FT, Lahoz C: Galectin-3 down-regulates IL-5 gene expression on different cell types. J Immunol. 1998, 161: 385-389.PubMed Cortegano I, del Pozo V, Cárdaba B, de Andrés B, Gallardo S, del Amo A, Arrieta I, Jurado A, Palomino P, Liu FT, Lahoz C: Galectin-3 down-regulates IL-5 gene expression on different cell types. J Immunol. 1998, 161: 385-389.PubMed
Metadata
Title
The increase of plasma galectin-9 in a patient with insulin allergy: a case report
Authors
Haorile Chagan-Yasutan
Beata Shiratori
Umme Ruman Siddiqi
Hiroki Saitoh
Yugo Ashino
Tomohiro Arikawa
Mitsuomi Hirashima
Toshio Hattori
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Clinical and Molecular Allergy / Issue 1/2010
Electronic ISSN: 1476-7961
DOI
https://doi.org/10.1186/1476-7961-8-12

Other articles of this Issue 1/2010

Clinical and Molecular Allergy 1/2010 Go to the issue